230 related articles for article (PubMed ID: 16626521)
1. Metabolism and effect of para-toluene-sulfonamide on rat liver microsomal cytochrome P450 from in vivo and in vitro studies.
Zhou JQ; Tang ZQ; Zhang JN; Tang JC
Acta Pharmacol Sin; 2006 May; 27(5):635-40. PubMed ID: 16626521
[TBL] [Abstract][Full Text] [Related]
2. An evaluation of para toluene-sulfonamide metabolism and effect with regard to CYP isoforms, P-glycoprotein, and drug interactions.
Zhou JQ; Tang ZQ; Zhang JN
Pharmazie; 2006 Oct; 61(10):869-73. PubMed ID: 17069428
[TBL] [Abstract][Full Text] [Related]
3. [Metabolites and metabolic pathways of mesaconitine in rat liver microsomal investigated by using UPLC-MS/MS method in vitro].
Bi YF; Liu S; Zhang RX; Song FR; Liu ZQ
Yao Xue Xue Bao; 2013 Dec; 48(12):1823-8. PubMed ID: 24689241
[TBL] [Abstract][Full Text] [Related]
4. Flavokawain A inhibits Cytochrome P450 in in vitro metabolic and inhibitory investigations.
Niu L; Ding L; Lu C; Zuo F; Yao K; Xu S; Li W; Yang D; Xu X
J Ethnopharmacol; 2016 Sep; 191():350-359. PubMed ID: 27318274
[TBL] [Abstract][Full Text] [Related]
5. Selectivities of human cytochrome P450 inhibitors toward rat P450 isoforms: study with cDNA-expressed systems of the rat.
Kobayashi K; Urashima K; Shimada N; Chiba K
Drug Metab Dispos; 2003 Jul; 31(7):833-6. PubMed ID: 12814958
[TBL] [Abstract][Full Text] [Related]
6. Rat and human liver cytochrome P-450 isoform metabolism of ecteinascidin 743 does not predict gender-dependent toxicity in humans.
Reid JM; Kuffel MJ; Ruben SL; Morales JJ; Rinehart KL; Squillace DP; Ames MM
Clin Cancer Res; 2002 Sep; 8(9):2952-62. PubMed ID: 12231541
[TBL] [Abstract][Full Text] [Related]
7. In-vitro metabolism of glycyrrhetinic acid by human and rat liver microsomes and its interactions with six CYP substrates.
Zhao K; Ding M; Cao H; Cao ZX
J Pharm Pharmacol; 2012 Oct; 64(10):1445-51. PubMed ID: 22943175
[TBL] [Abstract][Full Text] [Related]
8. The contribution of cytochrome P-450 isoenzymes to the metabolism of phenothiazine neuroleptics.
Daniel WA; Syrek M; Haduch A
Eur Neuropsychopharmacol; 2002 Oct; 12(5):371-7. PubMed ID: 12208554
[TBL] [Abstract][Full Text] [Related]
9. Metabolism and metabolic inhibition of gambogic acid in rat liver microsomes.
Liu YT; Hao K; Liu XQ; Wang GJ
Acta Pharmacol Sin; 2006 Sep; 27(9):1253-8. PubMed ID: 16923348
[TBL] [Abstract][Full Text] [Related]
10. Oxidation of 1,8-cineole, the monoterpene cyclic ether originated from eucalyptus polybractea, by cytochrome P450 3A enzymes in rat and human liver microsomes.
Miyazawa M; Shindo M; Shimada T
Drug Metab Dispos; 2001 Feb; 29(2):200-5. PubMed ID: 11159812
[TBL] [Abstract][Full Text] [Related]
11. Cytochrome P450 isoenzymes involved in rat liver microsomal metabolism of californine and protopine.
Paul LD; Springer D; Staack RF; Kraemer T; Maurer HH
Eur J Pharmacol; 2004 Feb; 485(1-3):69-79. PubMed ID: 14757125
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of ezlopitant, a nonpeptidic substance P receptor antagonist, in liver microsomes: enzyme kinetics, cytochrome P450 isoform identity, and in vitro-in vivo correlation.
Obach RS
Drug Metab Dispos; 2000 Sep; 28(9):1069-76. PubMed ID: 10950851
[TBL] [Abstract][Full Text] [Related]
13. Demethylation of radiolabelled dextromethorphan in rat microsomes and intact hepatocytes.
Di Marco A; Yao D; Laufer R
Eur J Biochem; 2003 Sep; 270(18):3768-77. PubMed ID: 12950260
[TBL] [Abstract][Full Text] [Related]
14. CYP3A4 mediated in vitro metabolism of vinflunine in human liver microsomes.
Zhao XP; Zhong J; Liu XQ; Wang GJ
Acta Pharmacol Sin; 2007 Jan; 28(1):118-24. PubMed ID: 17184591
[TBL] [Abstract][Full Text] [Related]
15. Recovery of hepatic function determined by cytochrome P450-dependent drug metabolism lags after compensatory hepatic volume changes after portal vein ligation in rats.
Takemura S; Minamiyama Y; Hirohashi K; Kubo S; Funae Y; Kinoshita H
J Surg Res; 2006 Aug; 134(2):285-91. PubMed ID: 16564546
[TBL] [Abstract][Full Text] [Related]
16. Characterization of cytochrome P-450 2D1 activity in rat brain: high-affinity kinetics for dextromethorphan.
Tyndale RF; Li Y; Li NY; Messina E; Miksys S; Sellers EM
Drug Metab Dispos; 1999 Aug; 27(8):924-30. PubMed ID: 10421620
[TBL] [Abstract][Full Text] [Related]
17. 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) modulates rat liver microsomal cyclophosphamide and ifosphamide activation by suppressing cytochrome P450 2C11 messenger RNA levels.
Chang TK; Chen H; Waxman DJ
Drug Metab Dispos; 1994; 22(5):673-9. PubMed ID: 7835216
[TBL] [Abstract][Full Text] [Related]
18. Cytochrome P450 enzymes involved in the metabolism of tetrahydrocannabinols and cannabinol by human hepatic microsomes.
Watanabe K; Yamaori S; Funahashi T; Kimura T; Yamamoto I
Life Sci; 2007 Mar; 80(15):1415-9. PubMed ID: 17303175
[TBL] [Abstract][Full Text] [Related]
19. Metabolism and metabolic inhibition of cilnidipine in human liver microsomes.
Liu XQ; Zhao Y; Li D; Qian ZY; Wang GJ
Acta Pharmacol Sin; 2003 Mar; 24(3):263-8. PubMed ID: 12617777
[TBL] [Abstract][Full Text] [Related]
20. Human reductive halothane metabolism in vitro is catalyzed by cytochrome P450 2A6 and 3A4.
Spracklin DK; Thummel KE; Kharasch ED
Drug Metab Dispos; 1996 Sep; 24(9):976-83. PubMed ID: 8886607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
